Year | Volume (Price x Shares) | Change |
---|---|---|
2024 | $1.21 M | -96.37% |
2023 | $33.36 M | 508.33% |
2022 | $5.48 M | -27.85% |
2021 | $7.6 M | 77.66% |
2020 | $4.27 M | -6.26% |
2019 | $4.56 M | -90.78% |
2018 | $49.5 M | 39.76% |
2017 | $35.42 M | 48.26% |
2016 | $23.89 M | -20.09% |
2015 | $29.89 M | 9.34% |
2014 | $27.34 M | 655.04% |
2013 | $3.62 M |
Company | FTD volume (3months) | FTD volume (1 year) | Country |
---|---|---|---|
Johnson & Johnson JNJ | $0.14 B | $0.60 B | ๐บ๐ธ USA |
Novartis NVS | $14.74 M | $89.79 M | ๐จ๐ญ Switzerland |
Pfizer PFE | $36.43 M | $0.32 B | ๐บ๐ธ USA |
Sanofi SNY | $25.9 M | $53.82 M | ๐ซ๐ท France |
Bristol-Myers Squibb BMY | $6.14 M | $0.10 B | ๐บ๐ธ USA |
AstraZeneca AZN | $0.10 B | $0.17 B | ๐ฌ๐ง UK |
Zogenix ZGNX | N/A | $54.53 M | ๐บ๐ธ USA |
Acorda Therapeutics
ACOR | N/A | $0.08 M | ๐บ๐ธ USA |
Teva Pharmaceutical Industries TEVA | $6.42 M | $44.32 M | ๐ฎ๐ฑ Israel |